Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9004)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 8, 2017 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tran-Minh ML, Sousa P, Maillet M, Allez M, Gornet JM. Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease. World J Hepatol 2017; 9(13): 613-626 [PMID: 28539989 DOI: 10.4254/wjh.v9.i13.613] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3214/full/v9/i13/613.htm |
| Number | Citing Articles |
| 1 |
Akira Hokama, Shingo Arakaki, Shinichiro Ishino, Yutaka Nakagawa, Souhei Tabata, Daiki Agarie, Satoshi Kuwae, Ryuta Zukeyama, Tatsuji Maeshiro, Yuma Tsuruta, Akiko Matsuzaki, Naoki Wada, Mitsuhisa Takatsuki, Jiro Fujita. Hepatocellular Carcinoma in a Patient With Crohn’s Disease. Cureus 2021; doi: 10.7759/cureus.16570
|
| 2 |
Macarena Klein, Paulina Núñez, Constanza Bay, Carolina Pizarro, Rocío Sedano, Rodrigo Quera. Liver Disorders in Inflammatory Bowel Disease. EMJ Hepatology 2020; : 26 doi: 10.33590/emjhepatol/20-00040
|
| 3 |
Afif Yaccob, Amir Mari. Practical clinical approach to the evaluation of hepatobiliary disorders in inflammatory bowel disease. Frontline Gastroenterology 2019; 10(3): 309 doi: 10.1136/flgastro-2018-101037
|
| 4 |
G. V. Volynets, A. I. Khavkin. Inflammatory bowel disease and drug-induced liver damage. Experimental and Clinical Gastroenterology 2021; (10): 138 doi: 10.31146/1682-8658-ecg-194-10-138-146
|
| 5 |
Scott D. Lee, Raina Shivashankar, Daniel Quirk, Haiying Zhang, Jean-Baptiste Telliez, John Andrews, Amy Marren, Arnab Mukherjee, Edward V. Loftus. Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments. Journal of Clinical Gastroenterology 2021; 55(3): 195 doi: 10.1097/MCG.0000000000001396
|
| 6 |
Paulina Núñez F, Rodrigo Quera, Constanza Bay, Fabiola Castro, Gabriel Mezzano. Drug-Induced Liver Injury Used in the Treatment of Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2022; 16(7): 1168 doi: 10.1093/ecco-jcc/jjac013
|
| 7 |
Anna Surówka, Michał Żołnierczuk, Piotr Prowans, Marta Grabowska, Patrycja Kupnicka, Marta Markowska, Joanna Olejnik-Wojciechowska, Zbigniew Szlosser, Aleksandra Wilk, Kamila Szumilas, Karolina Kędzierska-Kapuza. The Effects of Chronic Immunosuppressive Treatment on Morphological Changes in Cardiac Tissue and the Balance between Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitors in the Rat Heart. International Journal of Molecular Sciences 2024; 25(8): 4468 doi: 10.3390/ijms25084468
|
| 8 |
Sophie Vieujean, Edouard Louis. Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 2023; 16: 175628482311733 doi: 10.1177/17562848231173331
|
| 9 |
Marley L. Watson, Bridgette K. Schroader, Heather D. Nelkin. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2018; 40: 489 doi: 10.1016/bs.seda.2018.07.006
|
| 10 |
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Rendina. Liver involvement in inflammatory bowel disease: What should the clinician know?. World Journal of Hepatology 2021; 13(11): 1534-1551 doi: 10.4254/wjh.v13.i11.1534
|
| 11 |
Yaoyao Yan, Chen Xing, Yun Xiao, Xiaobao Shen, Zhaoyan Zhang, Chuanbiao He, Jing-Bo Shi, Mingming Liu, Xinhua Liu. Discovery and Anti-Inflammatory Activity Evaluation of a Novel CDK8 Inhibitor through Upregulation of IL-10 for the Treatment of Inflammatory Bowel Disease In Vivo. Journal of Medicinal Chemistry 2022; 65(10): 7334 doi: 10.1021/acs.jmedchem.2c00356
|
| 12 |
Min Li, Lulu Lan, Si Zhang, Yanjiao Xu, Wenxi He, Dong Xiang, Dong Liu, Xiuhua Ren, Chengliang Zhang. IL-6 downregulates hepatic carboxylesterases via NF-κB activation in dextran sulfate sodium-induced colitis. International Immunopharmacology 2021; 99: 107920 doi: 10.1016/j.intimp.2021.107920
|
| 13 |
Juliana Soares Severo, Vilk Jane da Silva Barros, Pedro Henrique Moraes Mendes, Brenda Lois Barros dos Santos, Alda Cássia Alves da Silva, Kelly Beatriz Vieira de Oliveira, Mayara Storel Bezerra de Moura, Poliana Cristina de Almeida Fonseca Viola, Nadir do Nascimento Nogueira, José Miguel Luz Parente, Murilo Moura Lima, Armênio Aguiar dos Santos, Moisés Tolentino Bento Silva. Phase angle values and ultra-processed food consumption are associated with changes in oxidative stress in inflammatory bowel disease patients. Clinical Nutrition ESPEN 2023; 57: 10 doi: 10.1016/j.clnesp.2023.06.006
|
| 14 |
Matteo Laspro, Ogechukwu C. Onuh, Kassandra Carrion, Hilliard T. Brydges, David L. Tran, Bachar F. Chaya, Augustus Parker, Vishal D. Thanik, Sheel Sharma, Eduardo D. Rodriguez. Vascularized Composite Allotransplantation of the Hand. Annals of Plastic Surgery 2023; 91(6): 771 doi: 10.1097/SAP.0000000000003659
|
| 15 |
Tadas Raudonis, Akvile Gliebute, Anna Greta Grigaityte, Zivile Lukosiunaite, Tatjana Karmaziene, Jurate Grigaitiene. A Six-Year Analysis of Biological Therapy for Severe Psoriasis in a Lithuanian Reference Centre of Dermatovenereology. Medicina 2020; 56(6): 275 doi: 10.3390/medicina56060275
|
| 16 |
Katharina Stratmann, Songül Aydolmus, Wenyi Gu, Dominik Heling, Ulrich Spengler, Birgit Terjung, Christian P. Strassburg, Richard Vollenberg, Irina Blumenstein, Jonel Trebicka. Hepatobiliary manifestations in patients with ulcerative colitis: a retrospective analysis. Frontiers in Medicine 2024; 10 doi: 10.3389/fmed.2023.1273797
|
| 17 |
Clinton B. Mathias, Jeremy P. McAleer, Doreen E. Szollosi. Pharmacology of Immunotherapeutic Drugs. 2020; : 175 doi: 10.1007/978-3-030-19922-7_6
|
| 18 |
Nicola Pugliese, Lucia Giuli, Elisabetta Mastrorocco, Francesco Santopaolo, Giacomo Marcozzi, Cristina Bezzio, Arianna Dal Buono, Roberto Gabbiadini, Antonio Gasbarrini, Francesca Romana Ponziani, Alessandro Armuzzi, Alessio Aghemo. Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative review. Digestive and Liver Disease 2023; doi: 10.1016/j.dld.2023.11.021
|
| 19 |
Hyun Jae Kim, Seonkyung Lee, Yu Jin Koo, Eunjin Kwon, Hyo-Jung Kim, Jeong-Yoon Choi, Ji-Soo Kim. Tacrolimus for Treating Orbital and Cranial Form of Idiopathic Inflammatory Pseudotumors. Journal of Clinical Neurology 2020; 16(4): 674 doi: 10.3988/jcn.2020.16.4.674
|
| 20 |
Yuzhu Cao, Hang Shi, Zhiguang Sun, Jiawei Wu, Yawen Xia, Yufei Wang, Yuanyuan Wu, Xiaoman Li, Wenxing Chen, Aiyun Wang, Yin Lu. Protective Effects of Magnesium Glycyrrhizinate on Methotrexate-Induced Hepatotoxicity and Intestinal Toxicity May Be by Reducing COX-2. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00119
|
| 21 |
Michele S. Barnhill, Joshua M. Steinberg, Joseph J. Jennings, James H. Lewis. Hepatotoxicty of Agents Used in the Management of Inflammatory Bowel Disease: a 2020 Update. Current Gastroenterology Reports 2020; 22(9) doi: 10.1007/s11894-020-00781-3
|
| 22 |
Mario Rivera-Izquierdo, Maria del Carmen Valero-Ubierna, Pelayo Nieto-Gómez, María Dolores Martínez-Bellón, Nicolás Francisco Fernández-Martínez, José Luis Barranco-Quintana. Vaccination in patients under monoclonal antibody treatment: an updated comprehensive review. Expert Review of Vaccines 2020; 19(8): 727 doi: 10.1080/14760584.2020.1800462
|
| 23 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|